TAMS enhances Nemio with 4D

Toshiba America Medical Systems Inc. (TAMS) has integrated its 4D imaging technology into its compact Nemio ultrasound system.

The full-featured Nemio delivers a wide range of clinical applications, including comprehensive OB/GYN, oncology and angiography studies. The new 4D imaging capabilities will include automated 3D volume acquisition and simultaneously displays real-time 2D images and continuously updates 3D volume for studies. The post-processing tools also will allow clinicians to more quickly and easily optimize the 3D volume dataset for the best possible 4D display, TAMS said.

TAMS announced additional advances for the Nemio such as: Tissue Harmonic Imaging (THI) for improved spatial resolution and reduced artifact for maximum diagnostic information; Quad Signal Processing (QSP) for four-times more data per transmission signal; Directional Color Angio that combines the sensitivity of color angiography with directional flow data to capture a more accurate representation of vascular anatomy; multi-frequency transducers including convex, linear and sector transducer capabilities with the ability to switch between harmonic and fundamental frequencies for optimal penetration; and simPACSUL, a fast and easy image management software package offering high capacity image storage and processing of single frame or cineloops of digital diagnostic data.

The Nemio featuring 4D imaging will be displayed at the Radiological Society of North America (RSNA) meeting, Nov. 28 - Dec. 2, in Chicago.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.